Organisation paid for research Program year 2025 Source: CMS Open Payments

Clinical Biotechnology Research

Neither a doctor nor a teaching hospital

Research payments

$184,019

10 payments

Through program year 2025, Clinical Biotechnology Research is reported as receiving $184,019 in research payments, across 10 payments.

By program year

3 rows
Year Kind Amount Payments
2025 Research $40,250 3
2020 Research $8,527 1
2019 Research $135,242 6

Breakdown

Who paid Research payments · program years 2019–2025
  1. Boehringer Ingelheim Pharmaceuticals, Inc. $77,849 2 payments
  2. Takeda Pharmaceuticals U.S.A., Inc. $65,921 5 payments
  3. Genzyme Corporation $35,250 1 payment
  4. Sanofi US Services Inc. $4,550 1 payment
  5. Pfizer Inc. $450 1 payment
Studies the money was for Research payments · program years 2019–2025
  1. PoCC dose finding in Mild to Moderate AD $77,849 2 payments
  2. Study to Qualify a Biomarker to Identify Subjects at Risk for MCI due to AD and to Evaluate Efficacy and Safety of Pioglitazone in Delaying Onset of MCI due to AD $65,921 5 payments
  3. A Single-arm, Open-label, Phase 2 Study Evaluating Subcutaneous Administration of Isatuximab, Administered by an On Body Delivery System, in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM) $35,250 1 payment
  4. A Prospective, Non-interventional, Multinational, Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM) $4,550 1 payment
  5. A Randomized Doubleblind Placebocontrolled Activecomparator Multicenter Phase 3 Study of Brentuximab Vedotin Or Placebo in Combination With Lenalidomide and Rituximab in Subjects With Relapsed Or Refractory Diffuse Large Bcell Lymphoma Dlbcl $450 1 payment
What the money was spent on Research payments · program years 2019–2025
  1. Other $65,921 5 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record